Rotavirus Infections
📧 Sign up to get email alerts when something new happens for Rotavirus Infections.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-24EMA Authorised: Rotarix (human rotavirus, live attenuated) — GlaxoSmithKline Biologicals S.A.
Rotarix (human rotavirus, live attenuated) by GlaxoSmithKline Biologicals S.A. has been authorised by the EMA for immunization against rotav…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults [Phase 1]
Phase 1 clinical trial of CDC-9 Inactivated Rotavirus Vaccine (IRV) in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults [Phase 1]
A Phase 1 study evaluating the CDC-9 Inactivated Rotavirus Vaccine delivered via a microneedle patch in healthy adults; the trial status is …
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
A completed clinical trial examining sanitation interventions and an oral rotavirus vaccine to evaluate impact on rotavirus infections and e…
-
EMA approval · 2025-12-18EMA Authorised: RotaTeq (rotavirus serotype G1;rotavirus serotype G2;rotavirus serotype G3;rotavirus serotype G4;rotavirus serotype P1) — Merck Sharp & Dohme B.V.
The EMA authorised RotaTeq (pentavalent rotavirus vaccine) by Merck Sharp & Dohme B.V. for immunization against rotavirus infections. This m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Phase II Clinical Trial of the Inactivated Rotavirus Vaccine [Phase 2]
Phase II clinical trial update for an inactivated rotavirus vaccine under investigation.
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine [Phase 2]
Phase II dose-ranging study of oral RV3-BB rotavirus vaccine completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years. [Phase 3]
Phase 3 trial update reporting safety and immunological efficacy of the pentavalent rotavirus vaccine Rota-V-Aid in healthy adults aged 18-4…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks [Phase 3]
Phase 3 safety study of two formulations of GSK's human rotavirus vaccine in healthy infants completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months [Phase 2]
Phase 2 trial evaluating protective efficacy of different strengths of a human rotavirus vaccine administered as 2 doses to two-month-old in…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of two formulations of GSK's human rotavirus vaccine in healthy infants; study completed …
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
A completed clinical trial update from GlaxoSmithKline reports rotavirus-related hospitalizations in Belgium during the 2010-2011 season.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. [Phase 2]
Phase 2 study evaluating immune response and safety of two doses of GSK's HRV liquid vaccine in healthy infants; trial completed with result…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults [Phase 1]
A Phase 1 study evaluating the safety and reactogenicity of the Rotarix rotavirus vaccine in Chinese adults has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants [Phase 1]
This Phase 1 safety study (NCT01107587) of GSK's liquid Rotavirus vaccine in healthy infants has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study to Evaluate the Safety of Rotarix™ in Chinese Children [Phase 1]
A completed Phase 1 trial assessing the safety of Rotarix rotavirus vaccine in Chinese children.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines [Phase 3]
A Phase 3 clinical trial evaluating prophylactic antipyretic treatment in children receiving pneumococcal conjugate and standard infant vacc…
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
This is a completed epidemiological, observational and post-marketing study of the Rotarix rotavirus vaccine in Belgian children with severe…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA [Phase 3]
Phase 3 study evaluating two doses of a rotavirus vaccine given with or around routine infant vaccines in healthy US infants has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine). [Phase 3]
A Phase 3 study in infants compared two preparations of the HRV Rotavirus vaccine (freeze-dried vs liquid); the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants [Phase 3]
A Phase 3 trial evaluating two doses of HRV vaccine given concomitantly with routine EPI vaccines including OPV in healthy infants. The stud…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis [Phase 3]
A Phase 3 trial evaluating two doses of an oral live attenuated HRV rotavirus vaccine for the prophylaxis of rotavirus gastroenteritis has c…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh [Phase 2]
A Phase 2 trial evaluated two doses of an HRV vaccine given with or without OPV in healthy infants in Bangladesh and has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa [Phase 2]
A Phase 2 trial evaluating the safety and immunogenicity of 2 or 3 doses of the GSK HRV vaccine in healthy infants in South Africa has compl…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV [Phase 2]
A Phase 2 trial evaluated two doses of GlaxoSmithKline's oral live attenuated human rotavirus vaccine co-administered with OPV or IPV; the s…